News: Transition Therapeutics Inc. (TTH.TO)

TTH.TO on Toronto Stock Exchange

8.39CAD
14 Dec 2009
Price Change (% chg)

$-0.17 (-1.99%)
Prev Close
$8.39
Open
--
Day's High
$8.50
Day's Low
$8.39
Volume
586
Avg. Vol
4,266
52-wk High
$9.77
52-wk Low
$3.50

view news for:
Select another date:

UPDATE 2-Elan, Transition drop top drug doses after deaths

* Nine deaths in patients on top doses of Alzheimer's drug

Continue Reading

Transition Therapeutic shares jump on trial results

* Trial results show high level of the drug stays in brain

UPDATE 1-Transition Therapeutics posts wider Q3 loss

May 13 (Reuters) - Canadian biopharmaceutical company Transition Therapeutics Inc posted a wider quarterly loss, hurt by lower interest income, loss on sale of shares and higher costs.

CANADA/RESEARCH

Goldcorp Inc UBS Cuts price target to

Transition gets Elan payment as sets Phase II test

NEW YORK, Dec 24 (Reuters) - Transition Therapeutics Inc said on Monday it will receive a $5 million milestone payment from Ireland's Elan Corp , as the company has begun Phase II testing of its Alzheimer's drug, ELND005.

UPDATE 1-Transition and Novo Nordisk end diabetes agreement

TORONTO, Nov 5 (Reuters) - Transition Therapeutics Inc said on Monday it will cancel its partnership agreement with Novo Nordisk AS on its diabetes program and take back all the rights held by Novo after the two companies failed to agree on licensing.

Transition ends diabetes pact with Novo Nordisk

TORONTO, Nov 5 (Reuters) - Transition Therapeutics Inc said on Monday it will cancel its partnership agreement with Novo Nordisk AS on its diabetes program and take back all its rights held by Novo after the two companies failed to come to terms on a licensing agreement.

Select another date:

Market Views

» More TTH.TO Market Views

Press Releases

view news for: